探讨阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的临床疗效.docVIP

精品论文 参考文献 探讨阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的临床疗效 和卫新（迪庆香格里拉人民医院 674400） 　　【摘要】 目的：探讨小儿肺炎支原体肺炎应用阿奇霉素联合孟鲁司特钠方案治疗的临床效果。方法：随机选取我院2013年11月-2014年11月期间收治的支原体肺炎(MP)患儿62例，平均分为两组，每组各有患儿31例，对照组患儿在常规治疗基础上联合阿奇霉素，观察组患儿在对照组治疗的基础上联合孟鲁司特钠。对比两组患儿的临床治疗效果和不良反应的发生概率。结果：对照组患儿临床治疗总有效率83.87%，观察组患儿临床治疗总有效率为96.77%，观察组患儿治疗总有效率明显优于对照组，差异有统计学意义(P＜0.05)；观察组患儿不良反应发生率为6.45%，相对于对照组患儿不良反应率9.68%，差异无统计学意义(P＞0.05)。结论：对小儿支原体肺炎患儿应用阿奇霉素联合孟鲁司特钠方案治疗优于单用阿奇霉素，不但取得了令人满意的临床治疗效果而且不会增加患儿不良反应的发生概率，具有安全高效的优点，有较高的临床价值，值得推广和广泛应用。 　　【关键词】 支原体肺炎；阿奇霉素；孟鲁司特钠【中图分类号】 R2 【文献标号】 A 【文章编号】 2095-7165(2015)14-09-02[Abstract] Objective：Explore Mycoplasma pneumoniae pneumonia azithromycin joint montelukast sodium regimen clinical effect .Methods：I randomlyselected hospital in November 2013 - November 2014 admitted during mycoplasma pneumonia (MP) in children 62 cases were divided into two groups,each group of children, 31 cases in the control group of children on the basis of conventional therapy azithromycin, patients in the observation group inthe control group on the basis of joint montelukast sodium . Comparison of the two groups of children with the probability of clinical therapeutic effectand adverse reactions .Results：A control group of children with clinical total effective rate 83.87%, children with clinical observation group total effectiverate 96.77%, treatment of children with clinical total effective rate was significantly better than the control group, the difference was statistically significant (Plt;0.05); group of children observed adverse reactions was 6.45%, compared to a control group of children with adverse reactions rate 9.68%, the differencewas not statistically significant (Pgt; 0.05).Conclusion: Children with mycoplasma pneumonia in children azithromycin joint montelukast regimen betterthan azithromycin, not only achieved satisfactory clinical results and will not increase the probability of occurrence of adverse reactions in children, has theadvantage of safe and effective, high clinical value, should be promot